These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 12322719)

  • 41. Industry-to-physician marketing and the cost of prescription drugs.
    Chiong W
    Am J Bioeth; 2003; 3(3):W28-W29. PubMed ID: 14594480
    [No Abstract]   [Full Text] [Related]  

  • 42. But first, call your drug company: the doctor-patient relationship is being replaced by a drug marketer-patient bond.
    Weissman RX
    Am Demogr; 1998 Oct; 20(10):27-30. PubMed ID: 10346668
    [No Abstract]   [Full Text] [Related]  

  • 43. Heal the damage: prescription drug consumer advertisements and relative choices.
    Gilhooley M
    J Health Law; 2005; 38(1):1-44. PubMed ID: 15968938
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FDA enlists doctors to help spot misleading drug advertisements.
    Tanne JH
    BMJ; 2010 May; 340():c2594. PubMed ID: 20472679
    [No Abstract]   [Full Text] [Related]  

  • 45. The new drug marketing: a consumer protection perspective.
    Woodward D
    Food Drug Law J; 1996; 51(4):637-50. PubMed ID: 11797733
    [No Abstract]   [Full Text] [Related]  

  • 46. When ads trump evidence: is direct-to-consumer advertising leading practice?
    Nelson R
    Am J Nurs; 2007 Oct; 107(10):25-6. PubMed ID: 17895720
    [No Abstract]   [Full Text] [Related]  

  • 47. Internet serving inquiring patients. Web powerful resource for health care providers, insurers.
    Johnson DE
    Profiles Healthc Mark; 1998; 14(3):23-6. PubMed ID: 10179503
    [No Abstract]   [Full Text] [Related]  

  • 48. Coming to terms with direct-to-consumer advertising.
    Curtis LG
    JAAPA; 2002 Jan; 15(1):6, 9. PubMed ID: 11845633
    [No Abstract]   [Full Text] [Related]  

  • 49. Pharmaceutical websites and the communication of risk information.
    Davis JJ; Cross E; Crowley J
    J Health Commun; 2007; 12(1):29-39. PubMed ID: 17365347
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surfing the Net in shallow waters: product liability concerns and advertising on the Internet.
    Moberg MA; Wood JW; Dorfman HL
    Food Drug Law J; 1998; 53(2):213-24. PubMed ID: 10346682
    [No Abstract]   [Full Text] [Related]  

  • 51. Problems associated with direct-to-consumer advertising (DTCA) of restricted, implantable medical devices: should the current regulatory approach be changed?
    Patsner B
    Food Drug Law J; 2009; 64(1):1-41. PubMed ID: 19998571
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J
    Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
    [No Abstract]   [Full Text] [Related]  

  • 53. Direct-to-consumer broadcast advertising: empowering the consumer or manipulating a vulnerable population?
    Reeves KN
    Food Drug Law J; 1998; 53(4):661-79. PubMed ID: 10557583
    [No Abstract]   [Full Text] [Related]  

  • 54. The ethical implications of direct-to-consumer pharmaceutical advertising.
    Farrell JM
    Philos Public Policy Q; 2003; 23(3):20-3. PubMed ID: 15282933
    [No Abstract]   [Full Text] [Related]  

  • 55. Drug firms back-pedal on direct advertising.
    Nature; 2005 Aug; 436(7053):910-1. PubMed ID: 16107811
    [No Abstract]   [Full Text] [Related]  

  • 56. FDA considers tightening regulations for direct-to-consumer advertising.
    Vastag B
    J Natl Cancer Inst; 2005 Dec; 97(24):1806-7. PubMed ID: 16368941
    [No Abstract]   [Full Text] [Related]  

  • 57. Direct-to-consumer pharmaceutical advertising: physician and public opinion and potential effects on the physician-patient relationship.
    Robinson AR; Hohmann KB; Rifkin JI; Topp D; Gilroy CM; Pickard JA; Anderson RJ
    Arch Intern Med; 2004 Feb; 164(4):427-32. PubMed ID: 14980994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Direct-to-consumer prescription drug advertising.
    Talley CR
    Am J Health Syst Pharm; 1997 Oct; 54(19):2181. PubMed ID: 9331437
    [No Abstract]   [Full Text] [Related]  

  • 59. You can't beat my marketing plan--or its price tag.
    Darrow GL
    Med Econ; 1991 Sep; 68(17):95-6. PubMed ID: 10112610
    [No Abstract]   [Full Text] [Related]  

  • 60. Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.
    Javitt GH; Stanley E; Hudson K
    Oklahoma Law Rev; 2004; 57(2):251-302. PubMed ID: 15658034
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.